Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 17/303% above fair value
$102.86+1.87 (+1.85%)
Close on Nov 13, 2026Market cap $131.57BP/E 25.3Yield 2.76%
Medtronic ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Medtronic's ebitda for the twelve months ending Jul 31, 2026 was $9.73B, up 7.2% year over year. For fiscal 2026 it was $9.43B, up 6.9% from the year before. Over ten years it grew 1.4% a year on average. The highest annual figure on record is $9.43B in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $9.43B | +6.9% |
| FY2025 | Apr 25, 2025 | $8.82B | +13.2% |
| FY2024 | Apr 26, 2024 | $7.79B | -4.8% |
| FY2023 | Apr 28, 2023 | $8.18B | -3.3% |
| FY2022 | Apr 29, 2022 | $8.46B | +17.7% |
| FY2021 | Apr 30, 2021 | $7.19B | -3.6% |
| FY2020 | Apr 24, 2020 | $7.45B | -16.5% |
| FY2019 | Apr 26, 2019 | $8.93B | -3.8% |
| FY2018 | Apr 27, 2018 | $9.28B | +11.9% |
| FY2017 | Apr 28, 2017 | $8.30B | +1.5% |
| FY2016 | Apr 29, 2016 | $8.18B | +61.3% |
| FY2015 | Apr 24, 2015 | $5.07B | +8.8% |
| FY2014 | Apr 25, 2014 | $4.66B | -10.7% |
| FY2013 | Apr 26, 2013 | $5.22B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $2.49B | +13.7% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $2.59B | +13.8% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $2.21B | -5.0% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $2.43B | +7.1% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $2.19B | +13.0% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $2.28B | +33.3% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $2.33B | +9.3% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $2.27B | +12.8% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $1.94B | 0.0% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $1.71B | -23.9% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $2.13B | +2.9% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $2.01B | -3.0% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $1.94B | +8.2% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $2.24B | -4.9% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $2.07B | -11.2% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $2.08B | -7.3% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $1.79B | +17.2% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $2.36B | +3.1% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $2.33B | +19.2% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $2.24B | +39.9% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $1.53B | +14.0% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $2.29B | +131.7% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $1.96B | -15.1% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $1.60B | -20.8% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $1.34B | -37.3% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $988.00M | -62.2% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $2.30B | +3.8% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $2.02B | -7.9% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $2.14B | +12.6% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $2.61B | +0.8% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $2.22B | +5.5% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $2.20B | -14.7% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $1.90B | -5.7% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $2.59B | +7.9% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $2.10B | +12.0% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $2.57B | +21.5% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $2.02B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $2.40B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $1.88B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $2.12B | – |
See a number that looks wrong?